Mega Genomics Limited

Equities

6667

KYG5960G1047

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. Other stock markets 04:08:24 2024-07-08 EDT			5-day change	1st Jan Change
9.6 ^HKD	-2.44%		-3.03%	-6.80%

06-28	Mega Genomics Limited Announces Change of Address of Principal Place of Business in Hong Kong	CI
06-28	Mega Genomics Limited Announces Change of Company Secretary	CI

Mega Genomics Limited Announces Change of Address of Principal Place of Business in Hong Kong

June 28, 2024 at 08:53 am

Mega Genomics Limited Board announced that the address of the principal place of business in Hong Kong of the Company will change its address from 5/F, Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong to: 28/F, Henley Building, 5 Queen's Road Central, Central, Hong Kong.

Latest news about Mega Genomics Limited

Mega Genomics Limited Announces Change of Address of Principal Place of Business in Hong Kong	06-28	CI
Mega Genomics Limited Announces Change of Company Secretary	06-28	CI
Mega Genomics Limited commences an Equity Buyback Plan for 23,632,360 shares, representing 10% of its issued share capital, under the authorization approved on June 28, 2024.	06-28	CI
Mega Genomics Limited's Equity Buyback announced on October 24, 2023, has expired.	06-27	CI
Mega Genomics Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Mega Genomics Stockholders to Vote March 1 on Continuing Transactions	02-12	MT
Mega Genomics Directors Terminate CEO	01-17	MT
Mega Genomics Limited Announces Resignation of Huang Yufeng as an Executive Director	01-17	CI
Mega Genomics Limited Announces Chief Executive Officer Changes	01-17	CI
Mega Genomics Limited commences an Equity Buyback Plan for 23,923,380 shares, representing 10% of its issued share capital, under the authorization approved on June 9, 2023.	23-10-24	CI
Mega Genomics Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-30	CI
Mega Genomics Eyes Buyback of Nearly 24 Million Shares	23-07-24	MT
Mega Genomics Limited Announces Resignation of Li Yan as Joint Company Secretary	23-07-21	CI
Certain Ordinary Shares of Mega Genomics Limited are subject to a Lock-Up Agreement Ending on 22-JUN-2023.	23-06-21	CI
Mega Genomics Warns of 2022 Loss	23-03-21	MT
Mega Genomics Limited Provides Group Earnings Guidance for the Year Ended 31 December 2022	23-03-20	CI
Certain Ordinary Shares of Mega Genomics Limited are subject to a Lock-Up Agreement Ending on 22-DEC-2022.	22-12-21	CI
Mega Genomics Limited Announces Change of Registered Office Address in the Cayman Islands	22-10-18	CI
Mega Genomics Completes Capital Reduction, Signs New Contracts	22-09-30	MT
Mega Genomics' H1 Profit Halves	22-09-27	MT
Mega Genomics Limited Change of Address of Principal Place of Business in Hong Kong	22-08-05	CI
Mega Genomics' Hong Kong IPO Stabilization Ends with No Overallotment	22-07-18	MT
Hong Kong Stocks Snap Three-Day Rally; Mega Genomics Wipes Out Early Gains in Debut	22-06-22	MT
Mega Genomics Defies Weak Sentiment for Hong Kong Debutants as Shares Rise 8% at Open	22-06-21	MT
Mega Genomics Limited has completed an IPO in the amount of HKD 215.3124 million.	22-06-21	CI

Chart Mega Genomics Limited

Duration

Period

More charts

Company Profile

Mega Genomics Ltd is a China-based investment holding company principally engaged in genetic testing business. The Company operates its businesses through three segments. The Consumer Genetic Testing Services segment provides testing for nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, pharmacogenetic testing and infectious disease testing. The Cancer Screening Services segment provides Septin9 colorectal cancer screening test, Syndecan-2 (SDC2) colorectal cancer screening test and ring finger protein 180 (RNF180)/Septin9 gastric cancer screening test. The Other Services segment provides genetic research and analysis services to third party research institutions.

Sector

Healthcare Facilities & Services

Calendar

2024-08-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
MEGA GENOMICS LIMITED	-6.80%	296M
SONIC HEALTHCARE LIMITED	-19.64%	8.46B
RADNET, INC.	+69.83%	4.41B
DR. LAL PATHLABS LIMITED	+12.75%	2.88B
SYNLAB AG	-2.80%	2.64B
NEOGENOMICS, INC.	-15.27%	1.73B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-59.82%	1.7B
FLEURY S.A.	-16.57%	1.5B
METROPOLIS HEALTHCARE LIMITED	+21.70%	1.25B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-50.86%	1.03B

Medical & Diagnostic Laboratories